Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 13 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2024        Dec 31, 2023      Mar 31, 2025 
                     LATEST             YEAR-AGO           LATEST    
                     RESULTS             RESULTS          FORECAST   
  Sales               2.07                1.78              2.66     
                   (+16.4 pct)         (-20.1 pct)       (+9.7 pct)  
  Operating       loss 180 mln        loss 289 mln      loss 325 mln 
  Recurring        loss 33 mln           58 mln         loss 174 mln 
  Net              loss 31 mln           48 mln         loss 174 mln 
  EPS             loss 0.34 yen         0.57 yen       loss 1.96 yen 
  EPS Diluted                           0.57 yen                     
  Ann Div                                  NIL              NIL      
  -Q2 div              NIL                 NIL                       
  -Q4 div                                  NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news